157 related articles for article (PubMed ID: 6207093)
21. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of pancreatic secretory trypsin inhibitor in human gastric mucosa.
Shibata T; Ogawa M; Matsuda K; Miyauchi K; Yamamoto T; Mori T
Clin Chim Acta; 1986 Aug; 159(1):27-36. PubMed ID: 3638992
[TBL] [Abstract][Full Text] [Related]
23. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.
Balldin G; Eddeland A; Ohlsson K
Scand J Gastroenterol; 1981; 16(5):603-9. PubMed ID: 6172839
[TBL] [Abstract][Full Text] [Related]
24. Purification of canine pancreatic secretory trypsin inhibitor and interaction in vitro with complexes of trypsin-alpha-macroglobulin.
Eddeland A; Ohlsson K
Scand J Clin Lab Invest; 1976 Dec; 36(8):815-20. PubMed ID: 73214
[TBL] [Abstract][Full Text] [Related]
25. Serum interleukin 6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thoraco-abdominal surgery.
Murata A; Ogawa M; Yasuda T; Nishijima J; Oka Y; Ohmachi Y; Hiraoka N; Niinobu T; Uda K; Mori T
Immunol Invest; 1990 Jun; 19(3):271-8. PubMed ID: 2114355
[TBL] [Abstract][Full Text] [Related]
26. Elimination of pancreatic secretory trypsin inhibitor from the circulation. A study in man.
Marks WH; Ohlsson K
Scand J Gastroenterol; 1983 Oct; 18(7):955-9. PubMed ID: 6676929
[TBL] [Abstract][Full Text] [Related]
27. [Serum pancreatic secretory trypsin inhibitor (PSTI), amylase activity and pancreatic isoamylase activity in pancreatic diseases].
Suehiro I; Otsuki M; Oka T; Okabayashi Y; Ohki A; Kanda T; Yuu H; Maeda M; Yamasaki T; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1984 Apr; 81(4):1044-9. PubMed ID: 6205183
[No Abstract] [Full Text] [Related]
28. The elimination of trypsin--alpha-macroglobulin complexes from the blood circulation in pigs during acute pancreatitis and after massive intravenous trypsin infusion.
Sjölund B; Lasson A; Ohlsson K
Scand J Clin Lab Invest; 1987 Apr; 47(2):131-41. PubMed ID: 2437645
[TBL] [Abstract][Full Text] [Related]
29. Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury.
Ogawa M; Matsuda K; Shibata T; Matsuda Y; Ukai T; Ohta M; Mori T
Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):259-66. PubMed ID: 2417295
[TBL] [Abstract][Full Text] [Related]
30. Purification of alpha 2-macroglobulin with trypsin-like activity from pleural fluids.
Bieth J; Klumpp T
Biochim Biophys Acta; 1976 Aug; 439(2):363-7. PubMed ID: 60136
[TBL] [Abstract][Full Text] [Related]
31. Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures.
Lasson A; Borgström A; Ohlsson K
Scand J Gastroenterol; 1986 Dec; 21(10):1275-80. PubMed ID: 3810002
[TBL] [Abstract][Full Text] [Related]
32. Elevation of circulating monitor peptide/pancreatic secretory trypsin inhibitor-I (PSTI-61) after turpentine-induced inflammation in rats: hepatocytes produce it as an acute phase reactant.
Uda K; Murata A; Nishijima J; Doi S; Tomita N; Ogawa M; Mori T
J Surg Res; 1994 Nov; 57(5):563-8. PubMed ID: 7526044
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic secretory proteins in sera from rats before and after induction of experimental pancreatitis.
Marks WH; Genell S; Hjelmqvist B; Ohlsson K
Scand J Gastroenterol; 1984 Jun; 19(4):552-60. PubMed ID: 6611580
[TBL] [Abstract][Full Text] [Related]
34. Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome.
Nakano I; Funakoshi A; Kimura T; Miyata Y; Koga S; Ibayashi H
Gastroenterol Jpn; 1986 Dec; 21(6):617-22. PubMed ID: 2436966
[TBL] [Abstract][Full Text] [Related]
35. Elevation of serum pancreatic secretory trypsin inhibitor following serious injury.
Shibata T; Ogawa M; Takata N; Niinobu T; Uda K; Ukai T; Ohta M; Mori T
Resuscitation; 1988 Jul; 16(3):163-8. PubMed ID: 2845540
[TBL] [Abstract][Full Text] [Related]
36. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course.
Lasson A; Ohlsson K
Scand J Gastroenterol; 1984 Sep; 19(6):779-86. PubMed ID: 6083596
[TBL] [Abstract][Full Text] [Related]
37. Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease.
Kato M; Hayakawa S; Naruse S; Kitagawa M; Nakae Y; Hayakawa T
J Clin Lab Anal; 1996; 10(6):399-402. PubMed ID: 8951609
[TBL] [Abstract][Full Text] [Related]
38. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
[TBL] [Abstract][Full Text] [Related]
39. Plasma levels of pancreatic secretory trypsin inhibitor in relation to amylase and lipase in patients with acute and chronic renal failure.
Hörl WH; Wanner C; Schollmeyer P; Ogawa M
Nephron; 1988; 49(1):33-8. PubMed ID: 2454413
[TBL] [Abstract][Full Text] [Related]
40. A sensitive two-site enzyme immunoassay for human pancreatic secretory trypsin inhibitor (PSTI) using monoclonal antibodies.
Kurobe M; Kono M; Yoshida N; Hayashi K
Clin Chim Acta; 1988 Dec; 178(2):205-14. PubMed ID: 3072118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
